Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

Autologous Fat Grafting as a Novel Antiestrogen Vehicle for the Treatment of Breast Cancer.

Thomas S, Chen S, Sbitany H, Kwon E, Piper M, Park J, Terranova Barberio M, Pawlowska N, Munster PN.

Plast Reconstr Surg. 2017 Sep;140(3):537-544. doi: 10.1097/PRS.0000000000003579.

PMID:
28841614
2.

Neither epithelial nor mesenchymal circulating tumor cells isolated from breast cancer patients are tumorigenic in NOD-scid Il2rgnull mice.

Donnenberg VS, Huber A, Basse P, Rubin JP, Donnenberg AD.

NPJ Breast Cancer. 2016 Mar 9;2:16004. doi: 10.1038/npjbcancer.2016.4. eCollection 2016.

3.

Non-glycanated Decorin Is a Drug Target on Human Adipose Stromal Cells.

Daquinag AC, Dadbin A, Snyder B, Wang X, Sahin AA, Ueno NT, Kolonin MG.

Mol Ther Oncolytics. 2017 May 17;6:1-9. doi: 10.1016/j.omto.2017.05.003. eCollection 2017 Sep 15.

4.

The Current Status of Stem-Cell Therapy in Erectile Dysfunction: A Review.

Reed-Maldonado AB, Lue TF.

World J Mens Health. 2016 Dec;34(3):155-164. doi: 10.5534/wjmh.2016.34.3.155. Epub 2016 Dec 22. Review.

5.

Cytokine signaling regulating adipose stromal cell trafficking.

Zhang Y, Kolonin MG.

Adipocyte. 2016 Aug 12;5(4):369-374. eCollection 2016 Oct-Dec.

6.

Expression of a Distinct Set of Chemokine Receptors in Adipose Tissue-Derived Stem Cells is Responsible for In Vitro Migration Toward Chemokines Appearing in the Major Pelvic Ganglion Following Cavernous Nerve Injury.

Albersen M, Berkers J, Dekoninck P, Deprest J, Lue TF, Hedlund P, Lin CS, Bivalacqua TJ, Van Poppel H, De Ridder D, Van der Aa F.

Sex Med. 2013 Aug;1(1):3-15. doi: 10.1002/sm2.1.

7.

Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells.

Strong AL, Burow ME, Gimble JM, Bunnell BA.

Stem Cells. 2015 Feb;33(2):318-26. doi: 10.1002/stem.1857. Review.

8.

Conversion of adipose-derived stem cells into natural killer-like cells with anti-tumor activities in nude mice.

Ning H, Lei HE, Xu YD, Guan RL, Venstrom JM, Lin G, Lue TF, Xin Z, Lin CS.

PLoS One. 2014 Aug 27;9(8):e106246. doi: 10.1371/journal.pone.0106246. eCollection 2014.

9.

Paracrine effects of stem cells in wound healing and cancer progression (Review).

Dittmer J, Leyh B.

Int J Oncol. 2014 Jun;44(6):1789-98. doi: 10.3892/ijo.2014.2385. Epub 2014 Apr 11. Review.

10.

A novel method to apply osteogenic potential of adipose derived stem cells in orthopaedic surgery.

Fang X, Murakami H, Demura S, Hayashi K, Matsubara H, Kato S, Yoshioka K, Inoue K, Ota T, Shinmura K, Tsuchiya H.

PLoS One. 2014 Feb 19;9(2):e88874. doi: 10.1371/journal.pone.0088874. eCollection 2014.

11.

The roles of mesenchymal stem cells in tumor inflammatory microenvironment.

Sun Z, Wang S, Zhao RC.

J Hematol Oncol. 2014 Feb 6;7:14. doi: 10.1186/1756-8722-7-14. Review.

12.

Endogenous gastric-resident mesenchymal stem cells contribute to formation of cancer stroma and progression of gastric cancer.

Kim EK, Kim HJ, Yang YI, Kim JT, Choi MY, Choi CS, Kim KH, Lee JH, Jang WH, Cheong SH.

Korean J Pathol. 2013 Dec;47(6):507-18. doi: 10.4132/KoreanJPathol.2013.47.6.507. Epub 2013 Dec 24.

13.

Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β.

Mele V, Muraro MG, Calabrese D, Pfaff D, Amatruda N, Amicarella F, Kvinlaug B, Bocelli-Tyndall C, Martin I, Resink TJ, Heberer M, Oertli D, Terracciano L, Spagnoli GC, Iezzi G.

Int J Cancer. 2014 Jun 1;134(11):2583-94. doi: 10.1002/ijc.28598. Epub 2014 Jan 30.

14.

Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment.

Brennen WN, Denmeade SR, Isaacs JT.

Endocr Relat Cancer. 2013 Aug 23;20(5):R269-90. doi: 10.1530/ERC-13-0151. Print 2013 Oct. Review.

15.

Mesenchymal stem cell secretome and regenerative therapy after cancer.

Zimmerlin L, Park TS, Zambidis ET, Donnenberg VS, Donnenberg AD.

Biochimie. 2013 Dec;95(12):2235-45. doi: 10.1016/j.biochi.2013.05.010. Epub 2013 Jun 5. Review.

16.

Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth.

Belmar-Lopez C, Mendoza G, Oberg D, Burnet J, Simon C, Cervello I, Iglesias M, Ramirez JC, Lopez-Larrubia P, Quintanilla M, Martin-Duque P.

BMC Med. 2013 May 28;11:139. doi: 10.1186/1741-7015-11-139.

17.

Natriuretic peptide receptor A signaling regulates stem cell recruitment and angiogenesis: a model to study linkage between inflammation and tumorigenesis.

Mallela J, Ravi S, Jean Louis F, Mulaney B, Cheung M, Sree Garapati U, Chinnasamy V, Wang C, Nagaraj S, Mohapatra SS, Mohapatra S.

Stem Cells. 2013 Jul;31(7):1321-9. doi: 10.1002/stem.1376.

18.

Quantification of Mesenchymal Stem Cells (MSCs) at sites of human prostate cancer.

Brennen WN, Chen S, Denmeade SR, Isaacs JT.

Oncotarget. 2013 Jan;4(1):106-17.

19.

Mesenchymal stem cells in tumor development: emerging roles and concepts.

Cuiffo BG, Karnoub AE.

Cell Adh Migr. 2012 May-Jun;6(3):220-30. doi: 10.4161/cam.20875. Epub 2012 May 1. Review.

20.

Implanted adipose progenitor cells as physicochemical regulators of breast cancer.

Chandler EM, Seo BR, Califano JP, Andresen Eguiluz RC, Lee JS, Yoon CJ, Tims DT, Wang JX, Cheng L, Mohanan S, Buckley MR, Cohen I, Nikitin AY, Williams RM, Gourdon D, Reinhart-King CA, Fischbach C.

Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9786-91. doi: 10.1073/pnas.1121160109. Epub 2012 Jun 4.

Supplemental Content

Support Center